Luke Vargas

I want to get to that point in a second, but there's clearly something here that people find valuable, enjoyable. Is the benefit that people are describing in this study mostly around, I don't know, being more efficient, making more money, saving time? What explains this uptick in use?

I want to get to that point in a second, but there's clearly something here that people find valuable, enjoyable. Is the benefit that people are describing in this study mostly around, I don't know, being more efficient, making more money, saving time? What explains this uptick in use?

The study found that the emerging economies are seeing greater AI adoption than more developed ones. How would you explain that?

The study found that the emerging economies are seeing greater AI adoption than more developed ones. How would you explain that?

Big opportunities here in everything from public health to efficiency within corporations. And yet, a few things jumped out to me. One that I imagine folks in legal departments will not be too pleased to hear, which is that you found that almost half of employees admit that they've used AI in ways that violate company policies.

Big opportunities here in everything from public health to efficiency within corporations. And yet, a few things jumped out to me. One that I imagine folks in legal departments will not be too pleased to hear, which is that you found that almost half of employees admit that they've used AI in ways that violate company policies.

This is things like uploading sensitive company information into free AI tools and that they've been relying on AI outputs at work without evaluating the accuracy of those results. These don't sound good.

This is things like uploading sensitive company information into free AI tools and that they've been relying on AI outputs at work without evaluating the accuracy of those results. These don't sound good.

David Rowlands, Global Head of AI at KPMG. Thank you so much for being with us on What's News.

David Rowlands, Global Head of AI at KPMG. Thank you so much for being with us on What's News.

We are exclusively reporting that a group of Wall Street's biggest banks, including Morgan Stanley, Bank of America, and five others, have finally dug themselves out of the $13 billion debt that they lent to Elon Musk for his takeover of Twitter, now X, in 2022. The $1.2 billion of unloved loans sold at 98 cents on the dollar.

We are exclusively reporting that a group of Wall Street's biggest banks, including Morgan Stanley, Bank of America, and five others, have finally dug themselves out of the $13 billion debt that they lent to Elon Musk for his takeover of Twitter, now X, in 2022. The $1.2 billion of unloved loans sold at 98 cents on the dollar.

Woodside Energy has given the go-ahead to the $17.5 billion development of an LNG gas export project in Louisiana. The Australian company is betting on strong ongoing demand for traditional fuels and the U.S. as a key supplier of natural gas to the global market. This includes customers in Asia and Europe who've been buying U.S. gas to counter dependence on Russia.

Woodside Energy has given the go-ahead to the $17.5 billion development of an LNG gas export project in Louisiana. The Australian company is betting on strong ongoing demand for traditional fuels and the U.S. as a key supplier of natural gas to the global market. This includes customers in Asia and Europe who've been buying U.S. gas to counter dependence on Russia.

In a move to ensure that cancer drugs are available to U.S. consumers, drugmaker Merck is investing in a $1 billion plant in Delaware ahead of potential tariffs targeting the industry. The facility will produce Merck's blockbuster cancer drug Keytruda, which treats lung cancer, melanoma and other tumors and accounts for roughly half of the company's revenue.

In a move to ensure that cancer drugs are available to U.S. consumers, drugmaker Merck is investing in a $1 billion plant in Delaware ahead of potential tariffs targeting the industry. The facility will produce Merck's blockbuster cancer drug Keytruda, which treats lung cancer, melanoma and other tumors and accounts for roughly half of the company's revenue.

And finally, it's going to be another busy day for markets, with a slew of earnings and data out later this morning. Finance editor Alex Frangos says these are the first economic readings following Trump's tariff announcements and will be closely watched for any indications of a U.S. downturn.

And finally, it's going to be another busy day for markets, with a slew of earnings and data out later this morning. Finance editor Alex Frangos says these are the first economic readings following Trump's tariff announcements and will be closely watched for any indications of a U.S. downturn.

And if you can't get enough earnings, check out the bonus episode we've got coming later today. In the next What's News in Earnings, we'll be looking at defense contractors. and how they expect the U.S. tariffs and a changing geopolitical environment to affect their business. That'll be in this feed around midday before our usual PM show tonight.

And if you can't get enough earnings, check out the bonus episode we've got coming later today. In the next What's News in Earnings, we'll be looking at defense contractors. and how they expect the U.S. tariffs and a changing geopolitical environment to affect their business. That'll be in this feed around midday before our usual PM show tonight.